C. Gomez

A phase 1b expansion study of TAS‐102 with oxaliplatin for refractory metastatic colorectal cancer

J. Lacy, J. Kortmansky, H. Hochster, 2020, Cancer.

A phase I study of TAS-102 in combination with oxaliplatin (TAS-OX) for refractory metastatic colorectal cancer (mCRC).

J. Lacy, J. Kortmansky, H. Hochster, 2019, Journal of Clinical Oncology.

A Phase II Trial of nab-Paclitaxel as Second-line Therapy in Patients With Advanced Pancreatic Cancer

I. Reis, P. Hosein, J. Merchan, 2013, American journal of clinical oncology.